Centre for Kidney Research School of Public Health Faculty of Medicine and Health Children's Hospital at WestmeadThe University of Sydney New South Wales Australia.
INSERM UMR 1033 University of LyonHospices Civils de Lyon Lyon France.
J Am Heart Assoc. 2021 Jan 19;10(2):e017205. doi: 10.1161/JAHA.120.017205. Epub 2021 Jan 13.
Background The prognostic importance of abdominal aortic calcification (AAC) viewed on noninvasive imaging modalities remains uncertain. Methods and Results We searched electronic databases (MEDLINE and Embase) until March 2018. Multiple reviewers identified prospective studies reporting AAC and incident cardiovascular events or all-cause mortality. Two independent reviewers assessed eligibility and risk of bias and extracted data. Summary risk ratios (RRs) were estimated using random-effects models comparing the higher AAC groups combined (any or more advanced AAC) to the lowest reported AAC group. We identified 52 studies (46 cohorts, 36 092 participants); only studies of patients with chronic kidney disease (57%) and the general older-elderly (median, 68 years; range, 60-80 years) populations (26%) had sufficient data to meta-analyze. People with any or more advanced AAC had higher risk of cardiovascular events (RR, 1.83; 95% CI, 1.40-2.39), fatal cardiovascular events (RR, 1.85; 95% CI, 1.44-2.39), and all-cause mortality (RR, 1.98; 95% CI, 1.55-2.53). Patients with chronic kidney disease with any or more advanced AAC had a higher risk of cardiovascular events (RR, 3.47; 95% CI, 2.21-5.45), fatal cardiovascular events (RR, 3.68; 95% CI, 2.32-5.84), and all-cause mortality (RR, 2.40; 95% CI, 1.95-2.97). Conclusions Higher-risk populations, such as the elderly and those with chronic kidney disease with AAC have substantially greater risk of future cardiovascular events and poorer prognosis. Providing information on AAC may help clinicians understand and manage patients' cardiovascular risk better.
在无创影像学检查中观察到的腹主动脉钙化(AAC)的预后重要性仍不确定。
我们搜索了电子数据库(MEDLINE 和 Embase)直到 2018 年 3 月。多名审查员确定了报告 AAC 和心血管事件或全因死亡率的前瞻性研究。两名独立审查员评估了纳入标准和偏倚风险,并提取了数据。使用随机效应模型比较较高的 AAC 组(任何或更高级别的 AAC)与报告的最低 AAC 组来估计汇总风险比(RR)。我们确定了 52 项研究(46 个队列,36092 名参与者);只有慢性肾脏病患者(57%)和一般老年人群(中位数 68 岁;范围 60-80 岁)的研究有足够的数据进行荟萃分析。任何或更高级别的 AAC 患者发生心血管事件的风险更高(RR,1.83;95%CI,1.40-2.39)、致命性心血管事件(RR,1.85;95%CI,1.44-2.39)和全因死亡率(RR,1.98;95%CI,1.55-2.53)。患有慢性肾脏病且存在任何或更高级别的 AAC 的患者发生心血管事件的风险更高(RR,3.47;95%CI,2.21-5.45)、致命性心血管事件(RR,3.68;95%CI,2.32-5.84)和全因死亡率(RR,2.40;95%CI,1.95-2.97)。
高危人群,如老年人和患有慢性肾脏病合并 AAC 的患者,未来发生心血管事件的风险更高,预后更差。提供 AAC 信息可能有助于临床医生更好地了解和管理患者的心血管风险。